Welcome, Paul Cassar - Licensing & Commercialization Associate, Business Intelligence

 

TDC is pleased to announce the arrival today of Paul Cassar, who joins us in the role of Licensing and Commercialization Associate – Business Intelligence.

Paul comes to us with extensive scientific business development and startup background, most recently from AdMare BioInnovations, where he was Manager, Business Development, assessing startup and valuation opportunities. 

Paul’s deep experience in product development and commercialization planning is a great asset to shaping fair-value investment opportunities for UHN technologies commercialized by TDC. He brings in rare strategic and valuation skills to bolster UHN’s company creation capabilities, with recent successes such as Northern Biologics,TCRyption, BlueRock Therapeutics, AVROBIO and others.

Paul’s previous roles include Director, Scientific Affairs (Stem Cell Network) and Scientist, Search & Evaluation (Centre for Drug Research and Development). He holds a Doctorate in Stem Cell Biology & Functional Genomics from the University of Toronto, and has been active in the community supporting educational initiatives as co-founder for Stem Cell Talks Canada.

Welcome, Paul!